Offer An Article

Pandemic Latest News

patent waiver

IP and breakthrough infections: Global Health Today

This is the third in a series of newsletters, offering the expert insight of Lalita Panicker – consulting editor, views, Hindustan Times, New Delhi – into some of the most pressing health issues of the day. This edition highlights vaccines – specifically, the IP debate and so-called breakthrough infections. To read the first, click here. COVID-19 …

IP and breakthrough infections: Global Health Today Read More »

Intellectual property in the era of COVID-19

Much of the conversation surrounding the COVID-19 pandemic in recent months has focused on access to vaccines – specifically, vaccine accesses in low- and middle-income countries. But to what extent is re-examining intellectual property (IP) rights part of the solution?  As Health Issues India reported in May, “patent waivers for COVID-19 vaccines have been offered …

Intellectual property in the era of COVID-19 Read More »

Patent waivers unlikely to resolve COVID-19 vaccine crisis

Patent waivers for COVID-19 vaccines have been offered up as a suggestion as a means to address the global crisis. While in theory this would allow a shift in production from high-income nations to developing countries, achieving this requires overcoming a significant hurdle – a lack of production capacity. Recently, World Health Organization (WHO) Director-General …

Patent waivers unlikely to resolve COVID-19 vaccine crisis Read More »